Appointment of Dr. Tarashree Singhal as Independent Woman Director and cessation of directorship of Mr. Srinivasan Venkataraman.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech's Board has appointed Dr. Tarashree Singhal as Additional Director/Independent Woman Director effective May 5, 2026, for a five-year term, subject to shareholder approval. Dr. Singhal holds an MBBS degree and a PG Diploma in Ultrasonography with 26 years of medical experience. Simultaneously, Mr. Srinivasan Venkataraman has completed his five-year tenure as Independent Director and ceased to be a director from close of business hours on May 5, 2026 (effective May 6, 2026), also ceasing his committee memberships. The appointment was recommended by the Nomination and Remuneration Committee and complies with SEBI LODR regulations.
The replacement of an independent director upon term completion is routine governance. Shareholders will vote on the new appointment. The appointment of a medical professional as an independent director may bring domain expertise to the board.